We are redefining cervical screening
10zyme is engineering biology to develop an innovative diagnostic technology that will empower women to effectively control their cervical health.
As an early-stage UK MedTech startup, we are pioneering a visionary approach to cervical screening. Our unique self-test delivers instant results for high-risk HPV, the virus responsible for over 99% of all cervical cancers.
Self-testing vs Self-collection
10zyme’s self-testing solution provides immediate, reliable results wherever and whenever the test is taken. In comparison, self-collection/sampling methods developed elsewhere only offer an alternative means of sample collection that still require transportation and laboratory testing, therefore leading to delays in obtaining results.
Self-testing will significantly increase screening uptake whilst reducing strain on vital healthcare resources, providing an accessible, convenient, and life-saving cancer prevention solution to all.
Our Research
Contributing to the global elimination of cervical cancer
Resources
A wealth of information in one place
24
Sep
Barriers to Cervical Screening: Addressing Common Challenges
Barriers to Cervical Screening: Addressing Common Challenges
12
Jul
Anal Cancer: Defining its Association With HPV
Anal Cancer: Defining its Association With HPV
Anal cancer ...
14
Jun
Human Papillomavirus: Understanding the Basic Facts
Human Papillomavirus: Understanding the Basic Facts